NDC11 14403340002
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 14403-3400-02 | 14403-3400 |
| 14403-3400-2 | 14403-3400 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Liraglutide | LIRAGLUTIDE | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 1a372465-d56b-2b80-e063-6394a90a3304 | 2024-12-03 | Warnings, Adverse reactions | 14403-3400-2 14403-3400 14403340002 |
| Liraglutide | LIRAGLUTIDE | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 1a36f43f-d734-97cc-e063-6294a90ae0da | 2024-12-02 | Warnings, Adverse reactions | 14403-3400 |
| Liraglutide | LIRAGLUTIDE | Hybio Pharmaceutical Co., Ltd. (Pingshan Factory) | 1a36b801-41e2-2eed-e063-6294a90a6f27 | 2024-06-05 | Warnings, Adverse reactions | 14403-3400 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.